TY - JOUR
T1 - Considerations for the Development of a Substance-Related Care and Prevention Continuum Model
AU - Perlman, David C.
AU - Jordan, Ashly E.
N1 - Publisher Copyright:
© Copyright © 2017 Perlman and Jordan.
PY - 2017/7/18
Y1 - 2017/7/18
N2 - There are significant gaps in the identification and engagement in care and prevention services of people who use illicit substances. Care continuum models have proven to be useful tools in the evaluation of care for HIV and other conditions; numerous issues in substance-related care and prevention resemble those identified in other continua models. Systems of care for substance misuse and substance use disorders (SUDs) can be viewed as consisting of a prevention and care continuum, reflecting incidence and prevalence of substance misuse and SUDs, screening and identification, medical and psychosocial evaluation for treatment, engagement in evidence-based treatment, treatment retention, relapse prevention, timeliness of step completion, and measures of overall and substance use-related specific morbidity and mortality. Care and prevention continuum models could potentially be applied at program, local, regional, state, and national levels. We discuss important lessons that can be drawn from applications of continuum models in other fields. The development and use of a substance-related care and prevention continuum may yield significant patient care, program evaluation and improvement, and population-level benefits.
AB - There are significant gaps in the identification and engagement in care and prevention services of people who use illicit substances. Care continuum models have proven to be useful tools in the evaluation of care for HIV and other conditions; numerous issues in substance-related care and prevention resemble those identified in other continua models. Systems of care for substance misuse and substance use disorders (SUDs) can be viewed as consisting of a prevention and care continuum, reflecting incidence and prevalence of substance misuse and SUDs, screening and identification, medical and psychosocial evaluation for treatment, engagement in evidence-based treatment, treatment retention, relapse prevention, timeliness of step completion, and measures of overall and substance use-related specific morbidity and mortality. Care and prevention continuum models could potentially be applied at program, local, regional, state, and national levels. We discuss important lessons that can be drawn from applications of continuum models in other fields. The development and use of a substance-related care and prevention continuum may yield significant patient care, program evaluation and improvement, and population-level benefits.
KW - care continuum
KW - illicit drug use
KW - program evaluation
KW - public health monitoring
KW - substance misuse
KW - substance use disorder
KW - substance use treatment
UR - http://www.scopus.com/inward/record.url?scp=85109782819&partnerID=8YFLogxK
U2 - 10.3389/fpubh.2017.00180
DO - 10.3389/fpubh.2017.00180
M3 - Article
AN - SCOPUS:85109782819
SN - 2296-2565
VL - 5
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 180
ER -